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Overview
The kidney plays a central role in the regulation of blood
pressure. It is the sole effector in the regulation of body
sodium balance and thus the extracellular fluid volume,
which is one of the major determinants of systemic blood
pressure. Furthermore, the kidney is physiologically the
only organ that generates renin, a key player in the
renin-angiotensin system and another major determinant
of systemic blood pressure. Extracellular fluid volume and
the renin-angiotensin system affect each other in a very
delicate manner in the kidney, which include afferent
arteriolar perfusion pressure, glomerular filtration fraction,
tubuloglomerular feedback through macula densa signal-
ing, angiotensin-regulated proximal sodium reabsorption,
and aldosterone-regulated distal sodium reabsorption.
Available evidence strongly indicates that the kidney is
primarily responsible for the genesis of essential hyperten-
sion. Thus, the results of renal cross transplantation exper-
iments in animal models of hypertension as well as those in
chronic dialysis patients with end-stage renal failure or
severe essential hypertension who received a renal trans-
plantation are instrumental to our better understanding of
and therapeutic intervention in the disease process.
Controlling systemic blood pressure as well as possibly
intraglomerular hypertension is the key to prevent the
relentless progression of chronic renal failure of a diverse
etiology. Studies in animals models of chronic renal failure
clearly define the renal mechanisms of the beneficial effects
of angiotensin blockade and perhaps of calcium channel
blockers. Studies in human subjects are less definitive, but
strongly suggest the benefit of controlling hypertension as a
key in the management of chronic renal disease. As sug-
gested, angiotensin blockade seems better than other
means to control blood pressure in preventing the progres-
sion of chronic renal failure, and thus angiotensin convert-
ing enzyme inhibitors have been widely used in clinical
settings.
Recently, another type of angiotensin blockade has be-
come clinically available, that is, angiotensin type 1 recep-
tor antagonists. This class of blockade of angiotensin action
is interesting in that it provides an opportunity to examine
in more detail the physiological and pathophysiological
significance of the angiotensin system in the regulation of
blood pressure and renal function. Indeed, angiotensin type
1 receptor blockade leads the potential action of angioten-
sin II through an unopposed angiotensin type 2 receptor. In
vivo studies show that such actions of angiotensin II are
often antiproliferative and apoptotic, which may be of a
greater value compared to angiotensin converting enzyme
blockade that effectively inhibits the action through both
types of receptors, in the management of chronic progres-
sive renal failure. However, data in support of such a
hypothesis are not available at present. Indeed, most data
currently available suggest that both classes of angiotensin
blocking agents have comparable effects on renal function
and progression of chronic renal disease.
The Symposium was organized by Professors Fernando
Valderra´bano and Jose´ Lun˜o with Spanish Society of
Nephrology and the Fundacio´n Renal In˜igo Alvarez de
Toledo. Merck Sharp and Dohme provided a grant to
support this very important scientific meeting. As you see in
this special issue, the Symposium has covered a wide range
of important topics pertaining to hypertension and the
kidney. Intense discussions among participants testify to
the interest and the quality of the program. It is notable
that “Nephrology Forum,” one of the most important
educational and teaching activities of the International
Society of Nephrology, was one of the highlights of the
Symposium. The “Forum” was chaired by Professor N.
Madias with the principal discussant, Professor J. Diez, who
gave an outstanding discussion on the role of IGF-1 in
essential hypertension. The International Society of Ne-
phrology is pleased to participate in this important educa-
tional program, and wishes to express its gratitude to the
Organizing Committee members and all those who were
involved in this endeavor.
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